United States · Bill · HR
H.R. 6102 (116th)
VALID Act of 2020
Introduced
5 March 2020
Last action
—
Status
Referred to the House Committee on Energy and Commerce.
Sponsors
—
Subjects
Discovery layer
Source updated
20 January 2026
Summary
Verifying Accurate Leading-edge IVCT Development Act of 2020 or the VALID Act of 2020 This bill requires the Food and Drug Administration to regulate in vitro clinical tests (i.e., tests intended for the collection, preparation, analysis, or in vitro clinical examination of specimens from the human body in order to provide information about a disease, condition, or treatment for a disease or condition).
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in House (text)
Introduced in House (text)
Introduced in House · EN · 5 March 2020
Introduced in House (PDF)
Introduced in House · EN · 5 March 2020
Introduced in House
summary · EN · 5 March 2020
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/116th-congress/house-bill/6102
- Open data entity: https://api.congress.gov/v3/bill/116/hr/6102